| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0021-9150(96)05864-9 |
| P8608 | Fatcat ID | release_aoqmjg2hojf6vaewn5zdv4png4 |
| P698 | PubMed publication ID | 8831922 |
| P5875 | ResearchGate publication ID | 222464028 |
| P2093 | author name string | Christiansen C | |
| Alexandersen P | |||
| Haarbo J | |||
| P433 | issue | 1 | |
| P921 | main subject | heart disease | Q190805 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 1-13 | |
| P577 | publication date | 1996-08-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | The relationship of natural androgens to coronary heart disease in males: a review | |
| P478 | volume | 125 |
| Q57110371 | Acne in Adolescence and Cause-specific Mortality: Lower Coronary Heart Disease but Higher Prostate Cancer Mortality |
| Q39164200 | Advancements in pharmacotherapy for angina. |
| Q35784175 | Age-related changes in testosterone and the role of replacement therapy in older men. |
| Q37756333 | Aging men and lipids |
| Q74528431 | Anabolic agents |
| Q44855302 | Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer |
| Q37600356 | Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling |
| Q58134737 | Androgen therapy in the aging male: assessing the effect on heart disease |
| Q43518215 | Androgenic anabolic steroids and arterial structure and function in male bodybuilders |
| Q58288724 | Andropause, androgen therapy and prostate safety |
| Q38139089 | Antagonist molecules in the treatment of angina |
| Q58291069 | Association of serum androgen concentrations with cardiovascular risk factors in elderly male patients with chronic systolic heart failure in China |
| Q45135523 | Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease |
| Q36501994 | Cardiovascular effects of androgen depletion and replacement therapy |
| Q43015198 | Cardiovascular effects of testosterone: implications of the "male menopause"? |
| Q45055926 | Combined effect of testosterone and apocynin on nitric oxide and superoxide production in PMA-differentiated THP-1 cells |
| Q33590717 | DHEA and DHEA-S: a review |
| Q43028516 | DHEA, important source of sex steroids in men and even more in women |
| Q43517521 | Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia |
| Q43948886 | Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). |
| Q44662619 | Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism |
| Q36509791 | Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms |
| Q54667227 | Dehydroepiandrosterone-mediated stimulation of sigma-1 receptor activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. |
| Q36446704 | Depression and coronary heart disease |
| Q44249460 | Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. |
| Q56774022 | Dihydrotestosterone Treatment Results in Obesity and Altered Lipid Metabolism in Orchidectomized Mice* |
| Q79222791 | Effect of dehydroepiandrosterone on cartilage and synovium of knee joints with osteoarthritis in rabbits |
| Q40035183 | Effect of smoking on semen quality, FSH, testosterone level, and CAG repeat length in androgen receptor gene of infertile men in an Indian city |
| Q43813835 | Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men. |
| Q73784633 | Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture |
| Q50927466 | Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis. |
| Q44406149 | Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects |
| Q46813482 | Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer |
| Q46155027 | Effects of varying doses of testosterone on atherogenic markers in healthy younger and older men. |
| Q37120820 | Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine |
| Q42952284 | Evaluation of a novel photoactive and biotinylated dehydroepiandrosterone analog |
| Q38515336 | Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis. |
| Q74445959 | Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids |
| Q41050656 | Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate |
| Q36850956 | Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. |
| Q31834528 | Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study |
| Q43419904 | Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis. |
| Q55245519 | Low testosterone in ApoE/LDL receptor double-knockout mice is associated with rarefied testicular capillaries together with fewer and smaller Leydig cells. |
| Q80193527 | Low testosterone levels are associated with coronary artery disease in male patients with angina |
| Q50925730 | Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. |
| Q35692900 | Male hypogonadism in the primary care clinic |
| Q45229032 | Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone |
| Q34380984 | Neuroendocrine aging in men. Andropause and somatopause |
| Q46769445 | PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1.2. |
| Q44478596 | Physiological testosterone replacement and arterial endothelial function in men. |
| Q46890605 | Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery. |
| Q37287696 | Progesterone levels and carotid intima-media thickness: a negative association in older northern Chinese men |
| Q34984090 | Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction |
| Q35925655 | Risks of testosterone replacement therapy in ageing men. |
| Q34940600 | Salivary sex hormone measurement in a national, population-based study of older adults |
| Q35547883 | Serum androgen-anabolic hormones and the risk of rheumatoid arthritis |
| Q46712908 | Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up. |
| Q51467198 | Serum testosterone level and related metabolic factors in men over 70 years old. |
| Q44844505 | Sex steroids and heart rate variability in patients after myocardial infarction. |
| Q77585738 | Simplified procedure for measurement of serum dehydroepiandrosterone and its sulfate with gas chromatography-ion trap mass spectrometry and selected reaction monitoring |
| Q42920776 | Synthesis and application of a photoaffinity analog of dehydroepiandrosterone (DHEA). |
| Q35197858 | Testosterone and atherosclerosis |
| Q34342113 | Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition. |
| Q44185072 | Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells |
| Q34171397 | Testosterone supplementation therapy for older men: potential benefits and risks |
| Q40707291 | Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages |
| Q93046502 | The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study |
| Q35738153 | The aging male: testosterone deficiency and testosterone replacement. An up-date |
| Q44408536 | The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs. |
| Q44807556 | The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs. |
| Q43938844 | The effects of cardiopulmonary bypass on androgen hormones in coronary artery bypass surgery. |
| Q44525452 | The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes |
| Q34544099 | The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies |
| Q58265908 | The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone) and coronary arteriosclerosis in men: The lower the androgens, the higher the coronary score of arteriosclerosis |
| Q58282320 | The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone), insulin, coagulation and fibrinolytic factors in men with coronary arteriosclerosis |
| Q35045086 | The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? |
| Q50858151 | Vascular reactivity is impaired in genetic females taking high-dose androgens. |
| Q45948653 | Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study. |
Search more.